Three new cases of non-Hodgkin lymphoma with t(9;14)(p13;q32). (Q47730555)

5 February 2018

title

Three new cases of non-Hodgkin lymphoma with t(9;14)(p13;q32). (English)

1 reference

5 February 2018

1 reference

Joris Andrieux

1

1 reference

5 February 2018

Sandra Fert-Ferrer

2

1 reference

5 February 2018

Marie-Christine Copin

3

1 reference

5 February 2018

Pauline Huyghe

4

1 reference

5 February 2018

Pierre Pocachard

5

1 reference

5 February 2018

James Lespinasse

6

1 reference

5 February 2018

Francis Bauters

7

1 reference

5 February 2018

Jean Luc Laï

8

1 reference

5 February 2018

Bruno Quesnel

9

1 reference

5 February 2018

publication date

1 August 2003

1 reference

5 February 2018

Cancer Genetics and Cytogenetics

published in

1 reference

5 February 2018

volume

145

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

65-69

1 reference

5 February 2018

Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Deletion 7q in B-cell low-grade lymphoid malignancies: a cytogenetic/fluorescence in situ hybridization and immunopathologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Cytogenetic studies in four cases of alpha chain disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hé

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

Deregulated expression of PAX5 in medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900054-2

7 January 2021

10.1016/S0165-4608(03)00054-2

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

12885465

1 reference

5 February 2018